Biomarkers associated with periimplant diseases
Related Experiment Video
Updated: Apr 24, 2026
Effects of Mechanical Methods Used in Peri-implantitis Treatment on Implant Surface Decontamination and Roughness
Published on: March 14, 2025
Jeff Yuanjun Li1, Hom-Lay Wang
1*Resident, Graduate Periodontics, Department of Periodontics and Oral Medicine, University of Michigan, School of Dentistry, Ann Arbor, MI. †Professor and Director of Graduate Periodontics, Graduate Periodontics, Department of Periodontics and Oral Medicine, University of Michigan, School of Dentistry, Ann Arbor, MI.
Purpose:
Recently, implantology has shifted its focus from implant placement to periimplant disease early detection, prevention, and treatment. The purpose of this article was to review the current understanding of the biomarkers associated with periimplant diseases.
Materials And Methods:
A search of PubMed was conducted up to August 2013 with keywords "peri-implantitis" and "biomarkers." Selected articles addressed the relationship between biomarkers and periimplant mucositis or peri-implantitis.
Results:
Biomarkers have been shown to possess potential in detecting periimplant diseases. For example, interleukin (IL)-1β levels were shown to be a good marker to detect periimplant mucositis lesions before they progress to peri-implantitis. Matrix metalloproteinase (MMP)-8 levels in periimplant sulcus fluid may be useful for monitoring the progression of periimplant disease. Osteoprotegerin (OPG) and receptor activator of NFκB ligand (RANKL) were found to be significantly higher in peri-implantitis sites compared with healthy implant sites.
Conclusion:
Biomarkers such as IL-1β, MMP-8, OPG, RANKL, and others have shown promising outcomes in differentiating from periimplant disease to health. However, because of varying results, additional evidence is needed to validate the links reported.
Related Concept Videos
01:30Bacterial Signaling
01:25Endocarditis II: Clinical Features of Infective Endocarditis
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...